Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Edwards Lifesciences (EW) PT Lowered to $200 at Raymond James
April 24, 2019 8:58 AM EDTRaymond James analyst Jayson Bedford lowered the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $210.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $200 at Stifel
April 24, 2019 8:36 AM EDTStifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $190.00) while maintaining a Buy rating.
Overall Solid Start to 2019 Despite Underwhelming 1Q19 TAVR Growth... MoreEdwards Lifesciences (EW) PT Raised to $186 at RBC Capital
April 24, 2019 6:39 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $182.00) while maintaining a Outperform rating following results.
... MoreEdwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook
April 23, 2019 4:16 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.32, $0.10 better than the analyst estimate of $1.22. Revenue for the quarter came in at $993 million versus the consensus estimate of $989.61 million.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.10-$5.35, from $5.05 to $5.30 and versus... More
